According to a market research report by BIS Research titled "Global Precision Medicine Market – Analysis and Forecast (2017-2026)," the global precision medicine market is expected to reach a value of $141.7 billion by the year 2026, wherein the oncology market segment is expected to grow at a compound annual growth rate (CAGR) of 10.4% from 2017 to 2026.

Orphan disease, by definition, is “any disease that affects a small percentage of the general population.” These diseases are often life-threatening, chronic, progressive, degenerative, and disabling, while most of them are linked to a genetic disorder and remain undiagnosed.

The U.S. weight loss market is estimated to be worth $68.2 billion in 2017—a 2.7% gain, and growth should continue into 2018, when the market is expected to post a better gain of 3.2% to $70 billion.

Continued high rates of obesity and overweight, coupled with low unemployment and higher disposable income, are boosting the market. However, performance will vary significantly by individual market segment.

3D bioprinting artificially constructs living tissue by applying layer-upon-layer of living cells. The deposition of live cells in combination with biological substances such as collagen, fibrin, and gelatin supports the growth of complete tissues and organs.

Cell-based research helps in the evaluation of diagnostic and therapeutic applications of various types of cells in the management of chronic and infectious diseases.

The availability of government support for promoting and supporting cell-based research activities, such as single-cell analysis and stem cell research, is driving research into the application and end-user industries for cell analysis.

The healthcare sector has moved from using paper-based records to electronically updated and shared records. This, in turn, has increased the demand for the Internet of Things (IoT) in healthcare to enable the collection and sharing of information directly through the Internet from anywhere in the world.

Medical device companies produce a wide variety of products such as wheelchairs, defibrillators, pacemakers, stents, and infusion pumps.

The medical device industry is highly regulated, and companies must invest in constant research and development in order to maintain a competitive edge.

In a recent survey of nearly 100 pharmaceutical and life science market research executives conducted by my company InCrowd, 80% identified their respective brand as being in a volatile market, characterized by disruption and uncertainty.

Life sciences tends to be a source of competitive and investor interest, because of its potential role in fighting disease and increasing human health. We asked one of our publishers, Kalorama Information, to talk about its recently published market studies. The publisher noted the following areas of health care.

According to a new market research report by BIS Healthcare titled Global Prefilled Syringes Market, Analysis & Forecast, 2017-2021, the global prefilled syringes market is expected to grow at a CAGR of 10.75%. In terms of volume, the market is expected to reach 8320.6 million units in 2021, growing at a CAGR of 12.31% during the forecast period 2017 to 2021.